Virtual Reality in the Treatment of Pelvic Floor Dysfunction in Women With Multiple Sclerosis
Effects of Virtual Reality in the Treatment of Pelvic Floor Dysfunction in Women With Multiple Sclerosis: A Randomized Clinical Trial
1 other identifier
interventional
45
0 countries
N/A
Brief Summary
The purpose of the current randomized clinical trial was to compare the effectiveness of virtual reality versus posterior tibial nerve stimulation on the improvement of pelvic floor dysfunctions in women with multiple sclerosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable multiple-sclerosis
Started Sep 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2024
CompletedFirst Posted
Study publicly available on registry
August 29, 2024
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedAugust 29, 2024
August 1, 2024
10 months
July 25, 2024
August 28, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pelvic floor strength
Pelvic floor strength using a perineometer, a device for measuring the strength of the pelvic floor, to which a speculum is adapted. measure force in newtons
At baseline, immediately after the intervention, and 4 weeks] [Safety Issue: No] It is a device for measuring the strength of the pelvic floor, to which a speculum is adapted. measure force in newtons
Secondary Outcomes (4)
Australian pelvic floor questionnaire:
At baseline, immediately after the intervention, and 4 weeks
Multiple Sclerosis Quality of Life-54 (MSQOL-54):
At baseline, immediately after the intervention, and 4 weeks
Euroqol
At baseline, immediately after the intervention, and 4 weeks
SF12
At baseline, immediately after the intervention, and 4 weeks
Study Arms (3)
Virtual reality therapy
EXPERIMENTALIt will ve placement of virtual reality glasses that will indicate to the patient when to contract the pelvic floor.
Neuromodulation of the tibialis posterior
EXPERIMENTALIs placed a external electrode 5 centimeters (cm) above the medial malleolus and 1 cm behind of the tibia and another electrode on the medial aspect of the foot, below the malleolus. The kind of electric current used will be rectangular, biphasic, with a pulse duration of 220 Ps and a frequency of 10 Hz. To avoid habituation to the current, a phase of 20 s stimulation with a 4 s rest phase. The intensity of the current will be inframotor, just below the contraction threshold of the flexor digitorum muscle brevis.
Pelvic Floor Muscle Training
EXPERIMENTALPatients will perform Pelvic Floor Muscle Training. Before performing this treatment at home, a session will be held with an expert physiotherapist in pelvic floor who will explain its implementation to the participants of this group.
Interventions
Participants receive virtual reality treatment, 8 weeks of treatment/ 2 times a week
Participants receive neuromodulation of the tibialis posterior nerve8 weeks of treatment/ 2 times a week/ 30 minutes
Participants receive pelvic floor muscle training 5 times a day for 9 weeks
Eligibility Criteria
You may qualify if:
- Diagnosis of multiple sclerosis
- Presence of pelvic floor dysfunction
- Acceptance participation
- Not undergoing another physical therapy treatment
You may not qualify if:
- Non-acceptance of participation
- Mental illness
- Interruption of adherence to protocolized treatment sessions
- Indication of surgical treatment in the pelvic floor
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guadalupe Molina Torres
Universidad de Almeria
- PRINCIPAL INVESTIGATOR
Jacobo Ángel Rubio-Arias
Universidad de Almeria
- PRINCIPAL INVESTIGATOR
Marta María Córdoba Peláez
Universidad de Almeria
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Single Blind (Subject)
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Lecturer
Study Record Dates
First Submitted
July 25, 2024
First Posted
August 29, 2024
Study Start
September 1, 2024
Primary Completion
July 1, 2025
Study Completion
December 1, 2025
Last Updated
August 29, 2024
Record last verified: 2024-08